Ascelia Pharma (Sweden) Probability of Future Stock Price Finishing Over 8.22
| ACE Stock | SEK 2.90 0.11 3.65% |
Ascelia |
Ascelia Pharma Target Price Odds to finish over 8.22
The tendency of Ascelia Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over kr 8.22 or more in 90 days |
| 2.90 | 90 days | 8.22 | close to zero percent |
Based on a normal probability distribution, the odds of Ascelia Pharma to move over kr 8.22 or more in 90 days from now is close to zero percent (This Ascelia Pharma AB probability density function shows the probability of Ascelia Stock to fall within a particular range of prices over 90 days) . Probability of Ascelia Pharma AB price to stay between its current price of kr 2.90 and kr 8.22 at the end of the 90-day period is about 1.1 .
Assuming the 90 days trading horizon Ascelia Pharma has a beta of 0.0839. This suggests as returns on the market go up, Ascelia Pharma average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Ascelia Pharma AB will be expected to be much smaller as well. Additionally Ascelia Pharma AB has an alpha of 0.5592, implying that it can generate a 0.56 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). Ascelia Pharma Price Density |
| Price |
Predictive Modules for Ascelia Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Ascelia Pharma AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Ascelia Pharma Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Ascelia Pharma is not an exception. The market had few large corrections towards the Ascelia Pharma's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Ascelia Pharma AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Ascelia Pharma within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.56 | |
β | Beta against Dow Jones | 0.08 | |
σ | Overall volatility | 0.24 | |
Ir | Information ratio | 0.08 |
Ascelia Pharma Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Ascelia Pharma for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Ascelia Pharma AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Ascelia Pharma AB is way too risky over 90 days horizon | |
| Ascelia Pharma AB appears to be risky and price may revert if volatility continues | |
| Ascelia Pharma AB has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (125.9 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ascelia Pharma AB has accumulated about 219.15 M in cash with (116.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.69, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 23.0% of the company shares are held by company insiders |
Ascelia Pharma Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Ascelia Stock often depends not only on the future outlook of the current and potential Ascelia Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Ascelia Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 261.6 M |
Ascelia Pharma Technical Analysis
Ascelia Pharma's future price can be derived by breaking down and analyzing its technical indicators over time. Ascelia Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Ascelia Pharma AB. In general, you should focus on analyzing Ascelia Stock price patterns and their correlations with different microeconomic environments and drivers.
Ascelia Pharma Predictive Forecast Models
Ascelia Pharma's time-series forecasting models is one of many Ascelia Pharma's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Ascelia Pharma's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Ascelia Pharma AB
Checking the ongoing alerts about Ascelia Pharma for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Ascelia Pharma AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Ascelia Pharma AB is way too risky over 90 days horizon | |
| Ascelia Pharma AB appears to be risky and price may revert if volatility continues | |
| Ascelia Pharma AB has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (125.9 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Ascelia Pharma AB has accumulated about 219.15 M in cash with (116.56 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.69, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 23.0% of the company shares are held by company insiders |
Additional Tools for Ascelia Stock Analysis
When running Ascelia Pharma's price analysis, check to measure Ascelia Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ascelia Pharma is operating at the current time. Most of Ascelia Pharma's value examination focuses on studying past and present price action to predict the probability of Ascelia Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ascelia Pharma's price. Additionally, you may evaluate how the addition of Ascelia Pharma to your portfolios can decrease your overall portfolio volatility.